Kuros Biosciences AG (CSBTF) Financials

CSBTF Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2025 135.2 million 50.8 million
June 30, 2025 138.7 million 42.0 million
Dec. 31, 2024 93.5 million 28.5 million
June 30, 2024 85.9 million 19.0 million

CSBTF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 1.2 million ?
June 30, 2025 -4.7 million 3.4 million
Dec. 31, 2024 3.3 million 2.4 million
June 30, 2024 -1.0 million 3.3 million

CSBTF Net Income

No data available :(

CSBTF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 19.7 million 4.3 million 736273
June 30, 2025 22.6 million 1.4 million 2.3 million
Dec. 31, 2024 19.3 million 1.4 million 2.0 million
June 30, 2024 15.9 million 1.5 million 2.2 million

CSBTF Shares Outstanding

No data available :(

CSBTF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 1.3 million 6.4 million 59.3 million -
June 30, 2025 1.3 million 5.4 million 61.2 million 47.2 million
Dec. 31, 2024 569488 3.8 million 17.4 million 19.6 million
June 30, 2024 663040 4.0 million 28.3 million 20.5 million

CSBTF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 83.3 million 12.2 million
June 30, 2025 80.1 million 9.0 million
Dec. 31, 2024 48.3 million 11.1 million
June 30, 2024 35.4 million 3.9 million

CSBTF

Price: $26

52 week price:
24.75
42.81

Earnings Per Share: -0.16 USD

Exchange: PNK

Sector: Healthcare

Industry: Medical Devices

Market Capitalization: 975.4 million

Links: